What is it about?

Antioxidant treatment for early postprandial hyperglycemia should be considered for patients with type 2 diabetes to support beta cell endogenous self-repair.

Featured Image

Read the Original

This page is a summary of: Antioxidants for Early Treatment of Type 2 Diabetes in Rodents and Humans: Lost in Translation?, Diabetes, February 2024, American Diabetes Association,
DOI: 10.2337/db23-0901.
You can read the full text:

Read

Contributors

Be the first to contribute to this page